A US biotechnology company has been given permission to try and bring 20 patients that have been declared clinically dead back to life, using a variety of therapies, including injecting the patient's spinal cords with stem cells. Commenting on the experimental trial, CEO of Bioquark, Dr Ira Pastor said he hoped to see results in 6 week, adding "It is a long-term vision of ours that a full recovery in such patients is a possibility, although that is not the focus of this first study – but it is a bridge to that eventuality." Experts were careful to manage expectations, saying that even if parts of the brain stem are nursed back to health with these therapies, "it's a long way from resurrecting a whole working brain, in a functional, undamaged state.”
A US biotechnology company has been given permission to try and bring 20 patients that have been declared clinically dead back to life, using a variety of therapies, including injecting the patient's spinal cords with stem cells. Commenting on the experimental trial, CEO of Bioquark, Dr Ira Pastor said he hoped to see results in the first two to three months, adding "It is a long-term vision of ours that a full recovery in such patients is a possibility, although that is not the focus of this first study – but it is a bridge to that eventuality." Experts were careful to manage expectations, saying that even if parts of the brain stem are nursed back to health with these therapies, "it's a long way from resurrecting a whole working brain, in a functional, undamaged state.”